Pharma Journalist - Page 895 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Mylan Completes Acquisition of Cold-EEZE Brand

Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon Skin Descaler

Mylan Completes Acquisition of Cold-EEZE Brand

Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline